![]() |
市場調查報告書
商品編碼
1679243
2030 年單細胞油市場預測:按微生物、等級、原料、應用和地區進行的全球分析Single Cell Oil Market Forecasts to 2030 - Global Analysis By Micro-Organisms (Bacteria, Yeast, Microalgae and Fungal), Grade (Fuel Grade, Feed Grade and Food Grade), Raw Material, Application and By Geography |
根據 Stratistics MRC 的數據,2024 年全球單細胞油市場價值為 6,855 萬美元,預計到 2030 年將達到 2.084 億美元,預測期內的複合年成長率為 20.36%。
由酵母、真菌和藻類等微生物培養而產生的油稱為單細胞油(SCO)。這些微生物油是傳統植物油和動物油的環保替代品,具有生產速度快、脂肪酸組成適應性強、水和土地消耗少等優點。 SCO 富含Omega-3和Omega-6脂肪酸,可用於食品、飼料、製藥和生質燃料應用。
根據國際能源總署(IEA)的數據,2021年生質燃料將佔全球運輸能源需求的3.6%左右,主要用於道路運輸。在淨零情境下,到 2030 年生質燃料對運輸的貢獻預計將增加四倍,達到 15%,相當於道路運輸總燃料需求的近五分之一。
人們對永續石油的興趣日益濃厚
人們對環境永續性的認知不斷提高,加上傳統石油開採造成的森林砍伐、棲息地破壞和溫室氣體排放,加速了對替代脂質來源的尋找。單細胞油(SCO)由藻類、真菌和酵母等微生物生產,被視為魚油、大豆油和棕櫚油的有前途的替代品,因為生產它們需要更少的土地和水。食品、化妝品和製藥業正在研究 SCO 作為永續的替代品,因為它可以生產高價值的脂質,而不會產生與傳統脂肪和油源相關的環境問題。
商業規模生產有限
即使採用目前的技術進步,擴大單細胞油的生產仍然極為困難。維持理想的生長條件、確保穩定的脂質積累、以及在不犧牲產量或品質的情況下有效提取油是阻礙從實驗室生產轉變為工業規模生產的一些挑戰。許多微生物需要精心調節的發酵條件,包括溫度、pH 值和營養物質的利用率,這增加了大規模生產的複雜性。此外,乾燥、榨油和細胞收穫等下游工序仍成本高昂且耗能。
人們對替代石油和永續石油的興趣日益濃厚
人們對棕櫚油和大豆油等傳統油類的環境問題的擔憂日益加劇,推動了對永續替代品的需求。單細胞油(SCO)由細菌、真菌和微藻類製成,是一種環保替代品,因為生產它不需要大量土地或砍伐森林。在食品、化妝品和工業應用中,對於尋求環保和永續脂質來源的產業來說,SCO 已成為棕櫚油和其他植物油的可行替代品。此外,SCO 的適應性脂肪酸組成使其適用於需要特定脂質特性的應用,從而增強了其在國際市場的吸引力。
來自傳統油脂的激烈競爭
全球食用油脂市場主要由棕櫚油、大豆油和魚油等低成本、廣泛供應的油類主導。由於產業聯繫、規模經濟和已建立的供應鏈,這些石油很難被取代。此外,SCO 對大多數製造商和消費者來說仍然相對較新且未知,而傳統油則擁有成熟的基本客群。為了與現有企業競爭,單細胞油必須展現出卓越的功能性和成本效益,即使在生質燃料、食品強化和Omega-3補充劑等利基市場。此外,如果沒有明顯的價格優勢或獨特優勢,SCO 的採用可能仍將局限於專門的應用領域。
COVID-19 疫情影響了許多行業的供應鏈、生產和需求動態,也以各種方式影響了單細胞油 (SCO) 市場。最初,SCO的生產和分銷受到勞動力短缺、全球供應鏈中斷和原料短缺的影響,導致生產延遲和成本增加。然而,疫情增加了消費者對增強免疫力的補充劑、營養保健食品和機能性食品的需求,並引發了人們對富含Omega-3脂肪酸(DHA 和 EPA)的 SCO 作為魚油永續替代品的興趣。
預計預測期內微藻類部分將成為最大的部分。
預計微藻類將在預測期內佔據最大的市場佔有率,因為它具有高脂質含量、優質的Omega-3脂肪酸組成(DHA 和 EPA),並且廣泛應用於食品、膳食補充劑和水產養殖。微藻類油是一種永續的、適合素食者的魚油和磷蝦油替代品,在動物飼料、營養補充劑和機能性食品中越來越受歡迎。對永續植物來源脂質源的需求不斷成長以及生物加工和大規模藻類培養市場的發展進一步增強了市場主導地位。此外,政府對生物基解決方案的舉措和投資也加速了研究和商業性應用,進一步鞏固了微藻類在 SCO 市場中的領先地位。
預計魚油替代品市場在預測期內將實現最高複合年成長率
由於食品、膳食補充劑和水產養殖中對永續植物來源的Omega-3 的需求不斷增加,預計魚油替代品領域將在預測期內呈現最高成長率。由於擔心過度捕撈、海洋污染和魚油供應減少,業界積極尋找富含 DHA 和 EPA 的替代脂質來源,基於微藻類的 SCO 是一種受歡迎的選擇。素食和純素飲食日益流行,以及人們對道德採購和環境永續性的認知不斷提高,也推動了需求。此外,大規模藻類培養和微生物發酵的發展使得生產更加經濟高效,使SCO成為水產飼料、營養保健品和機能性食品等各領域傳統魚油的有競爭力的替代品。
由於對生物技術和永續脂質生產的大量投資,以及消費者對植物來源Omega-3補充劑、營養保健品和機能性食品的強勁需求,市場佔有率。該地區的食品和營養補充劑行業已經很成熟,純素和替代油比傳統魚油和植物油越來越受歡迎。由於政府對生物基產業的支持、微生物發酵市場的發展以及 DSM、Corbion 和 Cargill 等主要參與者的大力研發,市場也在不斷成長。此外,隨著SCO在生質燃料、藥品和水產飼料領域的應用日益廣泛,北美的市場力量也進一步增強。
預計預測期內歐洲地區將呈現最高的複合年成長率。這是由嚴格的永續性法、對植物替代品日益成長的需求以及生物技術的突破所推動的。隨著該地區致力於減少對傳統魚類和植物油的依賴,基於微藻類的 SCO 在機能性食品、藥品和水產養殖中的應用越來越頻繁。德國、法國和英國等國家在生物技術研究和基於發酵的脂質生產方面處於領先地位,這進一步支持了市場的擴張。此外,隨著消費者對素食和永續的Omega-3來源的認知不斷提高,以及政府對生物基工業和再生能源來源的激勵措施,SCO 在食品、飼料和生質燃料的應用正在歐洲加速擴展。
According to Stratistics MRC, the Global Single Cell Oil Market is accounted for $68.55 million in 2024 and is expected to reach $208.40 million by 2030 growing at a CAGR of 20.36% during the forecast period. Oils made from microorganisms like yeast, fungus, and algae that are grown for their capacity to produce valuable lipids are referred to as single cell oil (SCO). These microbial oils are environmentally friendly substitutes for conventional plant and animal-based oils, with benefits like quick production, adaptable fatty acid composition, and low water and land consumption. SCOs are useful in food, feed, medicine, and bio fuel applications because they are especially high in omega-3 and omega-6 fatty acids.
According to the International Energy Agency (IEA), biofuels represented approximately 3.6% of the global transport energy demand in 2021, primarily for road transport. Under the Net Zero Scenario, the contribution of biofuels to transport is likely to quadruple to 15% by 2030, amounting to almost one-fifth of the total fuel demand for road transport alone.
Growing interest in sustainable oils
The hunt for alternative lipid sources has accelerated due to growing environmental sustainability consciousness and deforestation, habitat destruction, and greenhouse gas emissions caused by conventional oil extraction. Because single cell oils (SCOs), which are made from microorganisms like algae, fungi, and yeast, require less land and water than fish, soybean, or palm oils, they present a promising alternative. The food, cosmetic, and pharmaceutical industries are among those investigating SCO as a sustainable substitute due to its capacity to generate high-value lipids without the environmental problems associated with conventional oil sources.
Limited production on a commercial scale
Scaling up single-cell oil production is still very difficult, even with advances in technology. Keeping ideal growth conditions, guaranteeing steady lipid accumulation, and effectively extracting the oils without sacrificing yield or quality are some of the challenges that impede the shift from laboratory-scale to industrial-scale production. The complexity of large-scale production is increased by the fact that many microorganisms require carefully regulated fermentation conditions, such as temperature, pH, and nutrient availability. Additionally, downstream processing-this includes drying, oil extraction, and cell harvesting-remains costly and energy-intensive.
Growing interest in alternative and sustainable oils
The increasing environmental concerns surrounding conventional oils like palm and soybean oil have driven demand for sustainable alternatives. Single-cell oils (SCOs), which are made from bacteria, fungi, and microalgae, offer an environmentally friendly alternative because they can be made without requiring a lot of land or deforestation. In food, cosmetics, and industrial applications, SCOs have become viable alternatives to palm oil and other vegetable oils as industries look for environmentally friendly, sustainable lipid sources. Furthermore, they are also appropriate for applications that call for particular lipid profiles due to their adaptable fatty acid compositions, which increase their appeal on the international market.
Significant competition from traditional oils
The global edible oil and lipid markets are dominated by low-cost, widely available oils such as palm oil, soybean oil, and fish oil. These oils are hard to replace because of their established industry relationships, economies of scale, and well-established supply chains. Furthermore, while SCOs are still relatively new and unknown to the majority of manufacturers and consumers, traditional oils have a well-established customer base. To compete with current products, single-cell oils must demonstrate their superior functionality and cost-effectiveness, even in niche markets like biofuels, food fortification, and omega-3 supplements. Moreover, adoption of SCO may continue to be restricted to specialized applications in the absence of distinct price advantages or unique benefits.
The COVID-19 pandemic affected supply chains, production, and demand dynamics in a number of industries, with varying effects on the single cell oil (SCO) market. At first, SCO production and distribution were impacted by labor shortages, global supply chain disruptions, and raw material shortages, which resulted in delays and higher expenses. The pandemic did, however, also increase consumer demand for immune-boosting supplements, nutraceutical, and functional foods, which sparked interest in SCOs high in omega-3 fatty acids (DHA & EPA) as sustainable substitutes for fish oil.
The Microalgae segment is expected to be the largest during the forecast period
The Microalgae segment is expected to account for the largest market share during the forecast period due to its high lipid content, superior omega-3 fatty acid composition (DHA & EPA), and extensive use in food, nutraceuticals, and aquaculture. Microalgae-based oils are a sustainable and vegan-friendly substitute for fish and krill oil, increasing their popularity in animal feed, dietary supplements, and functional foods. The market's dominance has been further bolstered by the growing demand for plant-based and sustainable lipid sources, as well as by developments in bioprocessing and large-scale algal cultivation. Furthermore, government initiatives and investments in bio-based solutions have also accelerated research and commercial adoption, further solidifying microalgae's position as a leader in the SCO market.
The Fish Oil Substitute segment is expected to have the highest CAGR during the forecast period
Over the forecast period, the Fish Oil Substitute segment is predicted to witness the highest growth rate, driven by the rising demand for sustainable, plant-based omega-3 sources in food, nutraceuticals, and aquaculture. Microalgae-based SCOs are a popular option because industries are actively looking for alternative lipid sources rich in DHA and EPA due to worries about overfishing, marine pollution, and diminishing fish oil supplies. Demand is also being fueled by the growing popularity of vegetarian and vegan diets as well as heightened awareness of ethical sourcing and environmental sustainability. Moreover, developments in large-scale algal cultivation and microbial fermentation are increasing the cost-effectiveness and efficiency of production, making SCOs a competitive alternative to conventional fish oil in a variety of sectors, such as aquafeed, dietary supplements, and functional foods.
During the forecast period, the North America region is expected to hold the largest market share, driven by substantial investments in biotechnology and sustainable lipid production, as well as the strong consumer demand for plant-based omega-3 supplements, nutraceuticals, and functional foods. The food and dietary supplement industries in the area are well-established, and vegan and alternative oils are becoming more and more popular than conventional fish and vegetable oils. The market is also growing as a result of government support for bio-based industries, developments in microbial fermentation, and robust R&D efforts by major players like DSM, Corbion, and Cargill. Additionally, North America's market dominance is further cemented by the growing use of SCOs in biofuels, pharmaceuticals, and aquaculture feed.
Over the forecast period, the Europe region is anticipated to exhibit the highest CAGR, driven by stringent sustainability laws, growing demand for plant-based substitutes, and biotechnology breakthroughs. Because of the region's strong emphasis on lowering dependency on conventional fish and vegetable oils, microalgae-based SCOs are being used more frequently in functional foods, pharmaceuticals, and aquaculture. Market expansion is further supported by the fact that nations like Germany, France, and the UK are at the forefront of biotechnology research and fermentation-based lipid production. Furthermore, the expansion of SCO applications in food, feed, and biofuels in Europe is being accelerated by growing consumer awareness of vegan and sustainable omega-3 sources, as well as government incentives for bio-based industries and renewable energy sources.
Key players in the market
Some of the key players in Single Cell Oil market include Alltech Biotechnology Pvt. LTD, Hubei Xinhe Biotechnology Co. Ltd., Novozymes A/S, Royal DSM NV, Corbion N.V., Archer Daniels Midland (ADM), Cellana Inc, Goerlich Pharma GmbH, Evonik Industries AG, Cargill Incorporated, Xiamen Huison Biotech Co.Ltd., Bioriginal Food & Science Corp., Chevron Corporation, Omega Protein Corporation and TerraVia Holdings, Inc.
In April 2024, Corbion and Kingswood Capital Management, LP ("Kingswood"), a middle-market private equity firm with significant experience in corporate carve-outs have completed the earlier announced sale of Corbion's emulsifiers business. Kingswood acquired the emulsifier business from Corbion for a cash purchase price of $362M, with expected net cash proceeds of approximately $275M, post tax and transaction costs.
In December 2023, ADM announced that it has reached an agreement to acquire UK-based FDL, a leading developer and producer of premium flavor and functional ingredient systems. FDL, with projected 2023 sales of approximately $120 million, operates three production facilities and two customer innovation centers, all in the United Kingdom.
In December 2022, Novozymes and Chr. Hansen have entered into an agreement to create a leading global biosolutions partner through a statutory merger of the two companies. The combination is expected to unleash the full potential of biological solutions and generate significant value for all stakeholders and society at large.